✦ LIBER ✦

Topoisomerase I and IIα protein expression in primary colorectal cancer and recurrences following 5-fluorouracil-based adjuvant chemotherapy

✍ Scribed by Nicolas Tsavaris; Andreas Lazaris; Christos Kosmas; Panagiotis Gouveris; Nikolaos Kavantzas; Petros Kopterides; Thomas Papathomas; George Agrogiannis; Haralambos Zorzos; Vassiliki Kyriakou; Efstratios Patsouris

Publisher: Springer
Year: 2009
Tongue: English
Weight: 108 KB
Volume: 64
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s00280-009-0988-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Topoisomerase I and IIα protein expressi

Topoisomerase I and IIα protein expression in primary colorectal cancer and recurrences following 5-fluorouracil-based adjuvant chemotherapy

✍ Nicolas Tsavaris; Andreas Lazaris; Christos Kosmas; Panagiotis Gouveris; Nikolao 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 405 KB

Topoisomerase I protein expression in pr

Topoisomerase I protein expression in primary colorectal cancer and recurrences after 5-FU-based adjuvant chemotherapy

✍ P. Gouveris; A. C. Lazaris; T. G. Papathomas; A. Nonni; V. Kyriakou; J. Delladet 📂 Article 📅 2007 🏛 Springer-Verlag 🌐 English ⚖ 280 KB

Topoisomerase-I, thymidylate synthase pr

Topoisomerase-I, thymidylate synthase primary tumour expression and clinical efficacy of 5-FU/CPT-11 chemotherapy in advanced colorectal cancer patients

✍ Angelo Paradiso; JanMing Xu; Anita Mangia; Annalisa Chiriatti; Gianni Simone; Al 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 French ⚖ 229 KB

## Abstract While several studies have reported that thymidylate synthase (TS) tumour expression can be a reliable predictive marker of clinical response to 5‐Fluorouracil (5‐FU) for advanced colorectal cancer patients, only a few studies that searched for predictive factors of irinotecan (CPT‐11)

Topoisomerase II alpha protein and respo

Topoisomerase II alpha protein and responsiveness of breast cancer to adjuvant chemotherapy with CEF compared to CMF in the NCIC CTG randomized MA.5 adjuvant trial

✍ F. P. O’Malley; S. Chia; D. Tu; L. E. Shepherd; M. N. Levine; D. Huntsman; V. H. 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 355 KB

Phase 2 trial of primary systemic therap

Phase 2 trial of primary systemic therapy with doxorubicin and docetaxel followed by surgery, radiotherapy, and adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil based on clinical and pathologic response in patients with stage IIB to III breast cancer : Long-term results from The University of Texas M. D. Anderson Cancer Center Study ID97-099

✍ Ricardo H. Alvarez; Daniel J. Booser; Massimo Cristofanilli; Aysegul A. Sahin; E 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 199 KB 👁 2 views